药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Betaprodine
Vilanterol
The risk or severity of adverse effects can be increased when Vilanterol is combined with Baricitinib.
Betaprodine
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Baricitinib.
Betaprodine
Blinatumomab
The risk or severity of adverse effects can be increased when Blinatumomab is combined with Baricitinib.
Betaprodine
Vedolizumab
The risk or severity of adverse effects can be increased when Vedolizumab is combined with Baricitinib.
Betaprodine
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Baricitinib.
Betaprodine
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Dimethyl fumarate is combined with Baricitinib.
Betaprodine
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Baricitinib.
Betaprodine
Ruxolitinib
The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Baricitinib.
Betaprodine
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Baricitinib.
Betaprodine
Wortmannin
The risk or severity of adverse effects can be increased when Wortmannin is combined with Baricitinib.
Betaprodine
Bendamustine
The risk or severity of adverse effects can be increased when Bendamustine is combined with Baricitinib.
Betaprodine
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Baricitinib.
Betaprodine
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Baricitinib.
Betaprodine
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Baricitinib.
Betaprodine
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Baricitinib.
Betaprodine
Briakinumab
The risk or severity of adverse effects can be increased when Briakinumab is combined with Baricitinib.
Betaprodine
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Baricitinib.
Betaprodine
Interferon alfa
The risk or severity of adverse effects can be increased when Interferon alfa is combined with Baricitinib.
Betaprodine
Trabectedin
The risk or severity of adverse effects can be increased when Trabectedin is combined with Baricitinib.
Betaprodine
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Baricitinib.